Regulation of neurotransmission through presynaptic receptors and other mechanisms: possible clinical relevance and therapeutic potential.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001369:Axons / Q000378:metabolism; D001665:Binding Sites; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D009411:Nerve Endings / Q000378:metabolism; D009433:Neural Inhibition; D009638:Norepinephrine / Q000502:physiology*; D011941:Receptors, Adrenergic / Q000502:physiology*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology*; D017981:Receptors, Neurotransmitter / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects
D000929:Antidepressive Agents, Tricyclic; D006892:Hydroxydopamines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D017981:Receptors, Neurotransmitter; D009638:Norepinephrine